nach oben

Breast Cancer Research

Erschienen in:

01.02.2006 | Commentary

Recent translational research: stem cells as the roots of breast cancer

verfasst von: Chia-Cheng Chang

Erschienen in: Breast Cancer Research | Ausgabe 1/2005

Einloggen, um Zugang zu erhalten

Abstract

Common phenotypes of cancer and stem cells suggest that breast cancers arise from stem cells. Breast epithelial cells with stem cell phenotypes have been shown to be more susceptible to immortalization and neoplastic transformation. Breast tumor stem cells with CD44⁺/CD24^-/lowLineage^- markers have been isolated. The role of these cells in tumor progression and clinical outcome is not clear. The relationship between breast stem cell and tumor stem cell may be elucidated by further studies of carcinogenesis of nonadherent mammosphere cells with stem cell features and by derivation of CD44⁺/CD24^-/low cells from an adherent breast epithelial stem cell type.

Henahan D, Weinberg RA: The hallmarks of cancer. Cell. 2000, 100: 57-70. 10.1016/S0092-8674(00)81683-9.CrossRef

Trosko JE, Chang CC, Upham BL, Tai MH: Ignored hallmarks of carcinogenesis: stem cells and cell-cell communication. Ann N Y Acad Sci. 2004, 1028: 192-201. 10.1196/annals.1322.023.CrossRefPubMed

Tai MH, Chang CC, Kiupel M, Webster JD, Olson LK, Trosko JE: Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis. 2005, 26: 495-502. 10.1093/carcin/bgh321.CrossRefPubMed

Liu S, Dontu G, Wicha MS: Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res. 2005, 7: 86-95. 10.1186/bcr1021.CrossRefPubMedPubMedCentral

Russo IH, Koszalka M, Russo J: Human chorionic gonadotropin and rat mammary cancer prevention. J Natl Cancer Inst. 1990, 82: 1286-1289.CrossRefPubMed

Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Preston DL: Cancer incidence in atomic bomb survivors. Part II: Solid tumors 1958–1987. Radiat Res. 1994, S17-S67. Suppl

Kao CY, Nomata K, Oakley CS, Welsch CW, Chang CC: Two types of normal human breast epithelial cells derived from reduction mammoplasty: phenotypic characterization and response to SV40 transfection. Carcinogenesis. 1995, 16: 531-538.CrossRefPubMed

Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003, 17: 1253-1270. 10.1101/gad.1061803.CrossRefPubMedPubMedCentral

Dick DE: Normal and leukemic human stem cells assayed in SCID mice. Semin Immunol. 1996, 8: 197-206. 10.1006/smim.1996.0025.CrossRefPubMed

10.

Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63: 5821-5828.PubMed

11.

Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003, 100: 3983-3988. 10.1073/pnas.0530291100.CrossRefPubMedPubMedCentral

12.

Abraham BK, Fritz P, McClellan M, Hauptvogel P, Athelogou M, Brauch H: Prevalence of CD44⁺/CD24^-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clinical Cancer Res. 2005, 11: 1154-1159.

13.

Chang CC, Sun W, Cruz A, Saitoh M, Tai MH, Trosko JE: A human breast epithelial cell type with stem cell characteristics as target cells for carcinogenesis. Radiat Res. 2001, 155: 201-207.CrossRefPubMed

14.

Sun W, Kang KS, Morita I, Trosko JE, Chang CC: High susceptibility of a human breast epithelial cell type with stem cell characteristics to telomerase activation and immortalization. Cancer Res. 1999, 59: 6118-6123.PubMed

15.

Kang KS, Morita I, Cruz A, Jeon YJ, Trosko JE, Chang CC: Expression of estrogen receptors in a normal human breast epithelial cell type with luminal and stem cell characteristics and its neoplastically transformed cell lines. Carcinogenesis. 1997, 18: 251-257. 10.1093/carcin/18.2.251.CrossRefPubMed

16.

Chang CC: Normal adult breast stem cells as 'targets' for breast carcinogenesis implications for chemoprevention and chemotherapy. Proceedings of the Era of Hope Dept. of Defense Breast Cancer Res Program Meeting, 8–11 June 2005, Philadelphia, PA. 2005, Fort Detrick, MD: Department of the US Army Medical Research and Materiel Command, 256-

17.

Kang KS, Sun W, Nomata K, Morita I, Cruz A, Liu CJ, Trosko JE, Chang CC: Involvement of tyrosine phosphorylation of p185^C-erbB2/neu in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells. Mol Carcinog. 1998, 21: 225-233. 10.1002/(SICI)1098-2744(199804)21:4<225::AID-MC1>3.0.CO;2-J.CrossRefPubMed

18.

Lee SW, Tomasetto C, Sager R: Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc Natl Acad Sci USA. 1991, 88: 2825-2829.CrossRefPubMedPubMedCentral

19.

Sager R, Anisowicz A, Neveu M, Liang P, Sotiropoulou G: Identification by differential display of alpha 6 integrin as a candidate tumor suppressor gene. FASEB J. 1993, 7: 964-970.PubMed

20.

Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R: Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science. 1994, 263: 526-529.CrossRefPubMed

21.

Weiss S, Reynolds BA, Vescovi AL, Morshead CM, Craig CG, van der Kooy D: Is there a neural stem cell in the mammalian forebrain?. Trends Neurosci. 1996, 19: 387-393. 10.1016/S0166-2236(96)10035-7.CrossRefPubMed

22.

Wilson C, Dering J: Role of the ROR1 recceptor tyrosine kinase in ER-negative basal breast cancer. Proceedings of the Era of Hope Dept. of Defense Breast Cancer Res Program Meeting, 8–11 June 2005, Philadelphia, PA. 2005, Fort Detrick, MD: Department of the US Army Medical Research and Materiel Command, 25-

23.

Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X, Rowlands T, Egeblad M, Cowin P, Werb Z, et al: Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci USA. 2003, 100: 15853-15858. 10.1073/pnas.2136825100.CrossRefPubMedPubMedCentral

24.

Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 2005, 65: 5506-5511. 10.1158/0008-5472.CAN-05-0626.CrossRefPubMed

25.

Hope KJ, Jin L, Dick JE: Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol. 2004, 5: 738-743. 10.1038/ni1080.CrossRefPubMed

Titel: Recent translational research: stem cells as the roots of breast cancer
verfasst von: Chia-Cheng Chang
Publikationsdatum: 01.02.2006
Verlag: BioMed Central
Erschienen in: Breast Cancer Research / Ausgabe 1/2005
Elektronische ISSN: 1465-542X
DOI: https://doi.org/10.1186/bcr1385

Neu im Fachgebiet Onkologie

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Recent translational research: stem cells as the roots of breast cancer

Abstract

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2005

Spontaneous apoptosis of blood dendritic cells in patients with breast cancer

Comprehensive copy number profiles of breast cancer cell model genomes

Key stages in mammary gland development: The cues that regulate ductal branching morphogenesis

Overdiagnosis and overtreatment of breast cancer: Microsimulation modelling estimates based on observed screen and clinical data

Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines

Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie